Results 181 to 190 of about 16,198,215 (212)
Some of the next articles are maybe not open access.
Journal of the American Medical Directors Association, 2022
Meredith Yang +2 more
openaire +1 more source
Meredith Yang +2 more
openaire +1 more source
Advancing Virtual Primary Care for People with Opioid Use Disorder (VPC OUD)
The emergence of COVID-19 introduced a dual public health emergency in British Columbia, which in 2020 was already in the fourth year of its opioid-related overdose crisis. The public health response to COVID-19 must explicitly consider the unique needs of, and impacts on, communities experiencing marginalization including people with opioid use ...Spencer, Sarah, Hedden, Lindsay
openaire +1 more source
The Pharmacy Access to Resources and Medication for Opioid Use Disorder (PhARM-OUD) Guideline
Buprenorphine is the only agonist medication for opioid use disorder that may be dispensed directly to patients from a community pharmacy pursuant to a prescription from any Drug Enforcement Administration (DEA) licensed prescriber in all fifty states. The potential accessibility,Tyler Varisco +9 more
openaire +1 more source
Evidence Based Nursing, 2019
Commentary on : Hadland SE, Bagley SM, Rodean J, et al . Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder. JAMA Pediatrics . 2018;172(11):1029–1037. doi:10.1001/jamapediatrics.2018.2143.
openaire +2 more sources
Commentary on : Hadland SE, Bagley SM, Rodean J, et al . Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder. JAMA Pediatrics . 2018;172(11):1029–1037. doi:10.1001/jamapediatrics.2018.2143.
openaire +2 more sources